These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 16124950)

  • 21. The use of antithrombotics for acute coronary syndromes in the emergency department: considerations and impact.
    Mukherjee D; Eagle KA
    Prog Cardiovasc Dis; 2007; 50(3):167-80. PubMed ID: 17976502
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent trends in the care of patients with non-ST-segment elevation acute coronary syndromes: insights from the CRUSADE initiative.
    Mehta RH; Roe MT; Chen AY; Lytle BL; Pollack CV; Brindis RG; Smith SC; Harrington RA; Fintel D; Fraulo ES; Califf RM; Gibler WB; Ohman EM; Peterson ED
    Arch Intern Med; 2006 Oct; 166(18):2027-34. PubMed ID: 17030838
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antithrombotic therapy with fondaparinux in relation to interventional management strategy in patients with ST- and non-ST-segment elevation acute coronary syndromes: an individual patient-level combined analysis of the Fifth and Sixth Organization to Assess Strategies in Ischemic Syndromes (OASIS 5 and 6) randomized trials.
    Mehta SR; Boden WE; Eikelboom JW; Flather M; Steg PG; Avezum A; Afzal R; Piegas LS; Faxon DP; Widimsky P; Budaj A; Chrolavicius S; Rupprecht HJ; Jolly S; Granger CB; Fox KA; Bassand JP; Yusuf S;
    Circulation; 2008 Nov; 118(20):2038-46. PubMed ID: 18955665
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of enoxaparin in unselected patients with ST-segment elevation myocardial infarction.
    Zeymer U; Gitt A; Jünger C; Bauer T; Heer T; Koeth O; Wienbergen H; Zahn R; Senges J
    Thromb Haemost; 2008 Jan; 99(1):150-4. PubMed ID: 18217147
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical benefit of enoxaparin in patients with high-risk acute coronary syndromes without ST elevations in clinical practice.
    Zeymer U; Gitt A; Jünger C; Koeth O; Zahn R; Wienbergen H; Gottwik M; Senges J;
    Am J Cardiol; 2006 Jul; 98(1):19-22. PubMed ID: 16784913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Editor's Roundtable: arterial thrombosis and acute coronary syndromes.
    Friedewald VE; Bates ER; Granger CB; Yusuf S; Roberts WC
    Am J Cardiol; 2007 Sep; 100(6):974-80. PubMed ID: 17826381
    [No Abstract]   [Full Text] [Related]  

  • 27. Efficacy and safety of the low-molecular weight heparin enoxaparin compared with unfractionated heparin across the acute coronary syndrome spectrum: a meta-analysis.
    Murphy SA; Gibson CM; Morrow DA; Van de Werf F; Menown IB; Goodman SG; Mahaffey KW; Cohen M; McCabe CH; Antman EM; Braunwald E
    Eur Heart J; 2007 Sep; 28(17):2077-86. PubMed ID: 17600038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low molecular weight heparin and unfractionated heparin in thrombosis prophylaxis after major surgical intervention: update of previous meta-analyses.
    Bergqvist D
    Br J Surg; 1998 Jun; 85(6):872. PubMed ID: 9667723
    [No Abstract]   [Full Text] [Related]  

  • 29. A subgroup analysis of the impact of prerandomization antithrombin therapy on outcomes in the SYNERGY trial: enoxaparin versus unfractionated heparin in non-ST-segment elevation acute coronary syndromes.
    Cohen M; Mahaffey KW; Pieper K; Pollack CV; Antman EM; Hoekstra J; Goodman SG; Langer A; Col JJ; White HD; Califf RM; Ferguson JJ;
    J Am Coll Cardiol; 2006 Oct; 48(7):1346-54. PubMed ID: 17010793
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low molecular weight heparins could be important in cancer.
    Siragusa S
    BMJ; 1999 Sep; 319(7213):851. PubMed ID: 10496841
    [No Abstract]   [Full Text] [Related]  

  • 31. How should we define major bleeding events in thromboprophylaxis?
    Bottaro FJ; Ceresetto JM
    J Bone Joint Surg Am; 2010 Nov; 92(15):2617-8; author reply 2618-9. PubMed ID: 21048185
    [No Abstract]   [Full Text] [Related]  

  • 32. Enoxaparin in acute coronary syndromes: evidence for superiority over placebo or untreated control.
    Massel D; Cruickshank MK
    Am Heart J; 2002 May; 143(5):748-52. PubMed ID: 12040333
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interactions between heparins, glycoprotein IIb/IIIa antagonists, and coronary intervention. The Global Registry of Acute Coronary Events (GRACE).
    Brieger D; Van de Werf F; Avezum A; Montalescot G; Kennelly BM; Granger CB; Goodman SG; Dabbous OH; Agnelli G;
    Am Heart J; 2007 Jun; 153(6):960-9. PubMed ID: 17540196
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evolving management of ST-segment elevation myocardial infarction: update on recent data.
    Cannon CP
    Am J Cardiol; 2006 Dec; 98(12A):10Q-21Q. PubMed ID: 17169625
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The "superiority" of enoxaparin for treatment of acute coronary syndromes.
    Noviasky JA; Gaffney BJ
    Pharmacotherapy; 2001 Oct; 21(10):1250-2. PubMed ID: 11601672
    [No Abstract]   [Full Text] [Related]  

  • 36. Dosing considerations and monitoring of low molecular weight heparins and glycoprotein IIb/IIIa antagonists in patients with renal insufficiency.
    Rammohan C; Fintel D
    Curr Cardiol Rep; 2003 Jul; 5(4):303-9. PubMed ID: 12801450
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The safety and usefulness of low molecular weight heparins and unfractionated heparins in patients with acute stroke.
    Kiphuth IC; Köhrmann M; Huttner HB; Schellinger PD
    Expert Opin Drug Saf; 2009 Sep; 8(5):585-97. PubMed ID: 19614560
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Spontaneous pectoral hematoma secondary to enoxaparin for the treatment of deep venous thrombosis in an elderly man.
    Ozpolat B; Yazkan R; Aksoy M; Doğan S
    Anadolu Kardiyol Derg; 2008 Dec; 8(6):E40. PubMed ID: 19103532
    [No Abstract]   [Full Text] [Related]  

  • 39. Unfractionated and low-molecular-weight heparin as adjuncts to thrombolysis in aspirin-treated patients with ST-elevation acute myocardial infarction: a meta-analysis of the randomized trials.
    Eikelboom JW; Quinlan DJ; Mehta SR; Turpie AG; Menown IB; Yusuf S
    Circulation; 2005 Dec; 112(25):3855-67. PubMed ID: 16344381
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of non-Q-wave myocardial infarction.
    Roe MT; Bowen TE; Topol EJ
    N Engl J Med; 1998 Nov; 339(19):1396-7; author reply 1397-8. PubMed ID: 9841308
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.